Similar Search Results

Zur Kosten-Nutzen-Bewertung von Arzneimitteln

Glaeske, Gerd - In: Sozialer Fortschritt : unabhängige Zeitschrift für … 53 (2004) 8/9, pp. 229-235

Persistent link: https://www.econbiz.de/10002220311

Die Kosten-Nutzen-Bewertung von Arzneimitteln als Instrument der Gesundheitspolitik : Erfahrungen aus Australien, Kanada und Großbritannien ; 11 Tabellen

Rohrbacher, Rainer - 2006

Persistent link: https://www.econbiz.de/10003290550

Benefits and costs of methadone treatment : results from a lifetime simulation model

Zarkin, Gary A.; Dunlap, Laura J.; Hicks, Katherine A.; … - In: Health economics 14 (2005) 11, pp. 1133-1150

Persistent link: https://www.econbiz.de/10003183085

Can economic analysis contribute to the current debate on access to HIV/AIDS care in developing countries?

Kirman, Alan P.; Luchini, Stéphane; Moatti, Jean-Paul - In: Economie publique : revue de l'Institut d'Economie Publique (2003) 1, pp. 131-151

Persistent link: https://www.econbiz.de/10002151718

Saving lives, buying time : economics of malaria drugs in an age of resistance

Arrow, Kenneth Joseph (contributor); … - 2004

Persistent link: https://www.econbiz.de/10002146260

A reassessment of the cost-effectiveness of hormone replacement therapy in Sweden : results based on the Women's Health Initiative randomised controlled trial

Zethraeus, Niklas; Borgström, Fredrik; Jönsson, Bengt; … - 2004 - [Elektronische Ressource]

The cost-effectiveness of hormone replacement therapy (HRT) based on a societal perspective is reassessed based on new medical evidence found in the Women's Health Initiative (WHI). Within a model framework using an individual state transition model the cost-effectiveness of 50-60 year old women...

Persistent link: https://www.econbiz.de/10002482555